SoftOx Solutions AS works in a pan-European consortium to develop military countermeasures against chemical substances, biological agents, radioactive substances and nuclear material, so-called CBRN substances, for use in the Norwegian Armed Forces and the EU's military forces. InApril 2021 , SoftOx entered a three-year research collaboration with the Norwegian Defence Research Establishment (FFI) to improve the operational capability of Norwegian and international soldiers. In this connection, the subsidiary SoftOx Defense Solutions AS (SDS) was established. Based on SoftOx technology, SDS develops military applications for the Norwegian Armed Forces, the EU's military forces,NATO and the US Armed Forces. The work with the consortium lies in this company. The consortium is led byFrance and the application is sent to theEuropean Defense Fund (EDF) on9 December 2021 . The research work is based on SoftOx's technology as a basis for the development of military countermeasures and has a total estimated total of approx.NOK 500 million (Euro 50 million ). SDS's share is estimated at approximatelyNOK 120 million (Euro 12 million ) to develop a military inhalation solution for the EU. The company will apply to EDF to cover 80 percent of the costs associated with the project, ie NOK approx. 96 million (Euro 9.6 million ). The Norwegian contribution must account for the rest, ie approx.NOK 24 million (Euro 2.4 million ) TheMinistry of Defense has decided to guarantee 40 percent of the Norwegian contribution through so-called co-financing and has allocated SDS a total of 10.6 MNOK to the project. - This is a sign of quality and a declaration of confidence from the Ministry of Defence. We have big plans for SDS in the future, says CEOGeir Almås of SoftOx Solutions. For further information, please contact: CEOGeir Almås ofSoftOx Solutions AS , or Mail: ir@soft-ox.com Mobile: (+47) 948 59 599 AboutSoftOx Solutions AS SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a Norwegian BioTech company based inOslo with the aim of helping to combat major threats to human health, namely the emergence of antimicrobial resistance (AMR), biofilm infections in chronic wounds and the spread of viruses. For more information on SoftOx, visit www.soft-ox.com
Click here for more information
© Oslo Bors ASA, source